Sign in

CIK 0000874015

  • Large accelerated filer

IONIS PHARMACEUTICALS INC

Sign in to watch
Ticker
IONS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
330336973
Phone
+1 760-931-9200
Business address
2855 GAZELLE COURT, CARLSBAD, CA, 92010
Former names
ISIS PHARMACEUTICALS INC
Open-market buys, last 90 days
$148,200
in 1 filing
Open-market sales, last 90 days
$61,389
in 2 filings

Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-10 Hayden Michael R Director Purchase +5,000 $29.64 $148K 27,000
2026-10-16 Devers Shannon L. EVP, Chief Human Resources Ofc Sale −1,357 $43.54 $59K 17,811
2026-10-16 Swayze Eric EVP Research Sale −53 $43.54 $2K 390
2026-10-15 Devers Shannon L. EVP, Chief Human Resources Ofc Option exercise +2,820 19,168
2026-10-15 Devers Shannon L. EVP, Chief Human Resources Ofc Option exercise · Restricted Stock Unit −2,820 49,884
2026-10-15 Swayze Eric EVP Research Option exercise +125 443
2026-10-15 Swayze Eric EVP Research Option exercise · Restricted Stock Unit −125 486
2026-08-31 BENNETT C FRANK EVP, Chief Scientific Officer Other acquisition +110 $51.31 $6K 60,128
2026-08-31 O'NEIL PATRICK R. EVP CLO & General Counsel Other acquisition +63 $51.31 $3K 59,205
2026-08-31 Monia Brett P Chief Executive Officer Other acquisition +98 $51.31 $5K 242,760
2026-08-31 Birchler Brian EVP, Corp and Development Ops Other acquisition +58 $51.31 $3K 102,883
2026-07-31 Hayden Michael R Director Purchase +5,000 $51.60 $258K 24,000
2026-07-30 Hayden Michael R Director Purchase +15,000 $53.38 $801K 19,000
2026-07-15 Reikes Peter N Director Grant or award · Restricted Stock Unit +3,399 3,399
2026-07-15 HANTSON LUDWIG Director Grant or award · Restricted Stock Unit +3,399 3,399
2026-07-15 HERMAN JOAN E Director Option exercise +5,220 51,306
2026-07-15 HERMAN JOAN E Director Option exercise · Restricted Stock Unit −5,220 2,301
2026-07-15 BERTHELSEN SPENCER R Director Option exercise +5,220 161,233
2026-07-15 BERTHELSEN SPENCER R Director Option exercise · Restricted Stock Unit −5,220 2,301
2026-07-07 BENNETT C FRANK EVP, Chief Scientific Officer Sale 10b5-1 −5,536 $83.58 $463K 75,018

Page 1 of 34 · 668 trades